17856-0691 Ondansetron - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

17856-0691

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

Solution

Administration Route:

Oral

Substances:

Name: ONDANSETRON HYDROCHLORIDE

Strength: 4.0

Unit: mg/5mL

Packages:

Code: 17856-0691-01

Description: 1.5 mL in 1 SYRINGE (17856-0691-1)

Effective Date: April 17, 2024

Discontinued:

Code: 17856-0691-02

Description: 2.5 mL in 1 SYRINGE, PLASTIC (17856-0691-2)

Effective Date: April 17, 2024

Discontinued:

Code: 17856-0691-04

Description: 2.5 mL in 1 SYRINGE, PLASTIC (17856-0691-4)

Effective Date: April 17, 2024

Discontinued:

Code: 17856-0691-05

Description: 5 mL in 1 CUP (17856-0691-5)

Effective Date: April 17, 2024

Discontinued:

Code: 17856-0691-06

Description: 120 SYRINGE in 1 BOX, UNIT-DOSE (17856-0691-6) / 1.25 mL in 1 SYRINGE

Effective Date: April 17, 2024

Discontinued:

Code: 17856-0691-07

Description: 48 SYRINGE in 1 BOX, UNIT-DOSE (17856-0691-7) / 1.9 mL in 1 SYRINGE

Effective Date: April 17, 2024

Discontinued:

Code: 17856-0691-08

Description: 60 SYRINGE in 1 BOX, UNIT-DOSE (17856-0691-8) / 2.5 mL in 1 SYRINGE

Effective Date: April 17, 2024

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use